Cargando…

Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer

The Unity magnetic resonance (MR) linear accelerator (MRL) with MR‐guided adaptive radiotherapy (MRgART) is capable of online MRgART where images are acquired on the treatment day and the radiation treatment plan is immediately replanned and performed. We evaluated the MRgART plan quality and plan r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Shohei, Kadoya, Noriyuki, Ishizawa, Miyu, Katsuta, Yoshiyuki, Arai, Kazuhiro, Takahashi, Haruna, Xiao, Yushan, Takahashi, Noriyoshi, Sato, Kiyokazu, Takeda, Ken, Jingu, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691646/
https://www.ncbi.nlm.nih.gov/pubmed/37559561
http://dx.doi.org/10.1002/acm2.14122
_version_ 1785152778501357568
author Tanaka, Shohei
Kadoya, Noriyuki
Ishizawa, Miyu
Katsuta, Yoshiyuki
Arai, Kazuhiro
Takahashi, Haruna
Xiao, Yushan
Takahashi, Noriyoshi
Sato, Kiyokazu
Takeda, Ken
Jingu, Keiichi
author_facet Tanaka, Shohei
Kadoya, Noriyuki
Ishizawa, Miyu
Katsuta, Yoshiyuki
Arai, Kazuhiro
Takahashi, Haruna
Xiao, Yushan
Takahashi, Noriyoshi
Sato, Kiyokazu
Takeda, Ken
Jingu, Keiichi
author_sort Tanaka, Shohei
collection PubMed
description The Unity magnetic resonance (MR) linear accelerator (MRL) with MR‐guided adaptive radiotherapy (MRgART) is capable of online MRgART where images are acquired on the treatment day and the radiation treatment plan is immediately replanned and performed. We evaluated the MRgART plan quality and plan reproducibility of the Unity MRL in patients with prostate cancer. There were five low‐ or moderate‐risk and five high‐risk patients who received 36.25 Gy or 40 Gy, respectively in five fractions. All patients underwent simulation magnetic resonance imaging (MRI) and five online adaptive MRI. We created plans for 5, 7, 9, 16, and 20 beams and for 60, 100, and 150 segments. We evaluated the target and organ doses for different number of beams and segments, respectively. Variation in dose constraint between the simulation plan and online adaptive plan was measured for each patient to assess plan reproducibility. The plan quality improved with the increasing number of beams. However, the proportion of significantly improved dose constraints decreased as the number of beams increased. For some dose parameters, there were statistically significant differences between 60 and 100 segments, and 100 and 150 segments. The plan of five beams exhibited limited reproducibility. The number of segments had minimal impact on plan reproducibility, but 60 segments sometimes failed to meet dose constraints for online adaptive plan. The optimization and delivery time increased with the number of beams and segments. We do not recommend using five or fewer beams for a reproducible and high‐quality plan in the Unity MRL. In addition, many number of segments and beams may help meet dose constraints during online adaptive plan. Treatment with the Unity MRL should be performed with the appropriate number of beams and segments to achieve a good balance among plan quality, delivery time, and optimization time.
format Online
Article
Text
id pubmed-10691646
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106916462023-12-02 Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer Tanaka, Shohei Kadoya, Noriyuki Ishizawa, Miyu Katsuta, Yoshiyuki Arai, Kazuhiro Takahashi, Haruna Xiao, Yushan Takahashi, Noriyoshi Sato, Kiyokazu Takeda, Ken Jingu, Keiichi J Appl Clin Med Phys Radiation Oncology Physics The Unity magnetic resonance (MR) linear accelerator (MRL) with MR‐guided adaptive radiotherapy (MRgART) is capable of online MRgART where images are acquired on the treatment day and the radiation treatment plan is immediately replanned and performed. We evaluated the MRgART plan quality and plan reproducibility of the Unity MRL in patients with prostate cancer. There were five low‐ or moderate‐risk and five high‐risk patients who received 36.25 Gy or 40 Gy, respectively in five fractions. All patients underwent simulation magnetic resonance imaging (MRI) and five online adaptive MRI. We created plans for 5, 7, 9, 16, and 20 beams and for 60, 100, and 150 segments. We evaluated the target and organ doses for different number of beams and segments, respectively. Variation in dose constraint between the simulation plan and online adaptive plan was measured for each patient to assess plan reproducibility. The plan quality improved with the increasing number of beams. However, the proportion of significantly improved dose constraints decreased as the number of beams increased. For some dose parameters, there were statistically significant differences between 60 and 100 segments, and 100 and 150 segments. The plan of five beams exhibited limited reproducibility. The number of segments had minimal impact on plan reproducibility, but 60 segments sometimes failed to meet dose constraints for online adaptive plan. The optimization and delivery time increased with the number of beams and segments. We do not recommend using five or fewer beams for a reproducible and high‐quality plan in the Unity MRL. In addition, many number of segments and beams may help meet dose constraints during online adaptive plan. Treatment with the Unity MRL should be performed with the appropriate number of beams and segments to achieve a good balance among plan quality, delivery time, and optimization time. John Wiley and Sons Inc. 2023-08-10 /pmc/articles/PMC10691646/ /pubmed/37559561 http://dx.doi.org/10.1002/acm2.14122 Text en © 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Tanaka, Shohei
Kadoya, Noriyuki
Ishizawa, Miyu
Katsuta, Yoshiyuki
Arai, Kazuhiro
Takahashi, Haruna
Xiao, Yushan
Takahashi, Noriyoshi
Sato, Kiyokazu
Takeda, Ken
Jingu, Keiichi
Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title_full Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title_fullStr Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title_full_unstemmed Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title_short Evaluation of Unity 1.5 T MR‐linac plan quality in patients with prostate cancer
title_sort evaluation of unity 1.5 t mr‐linac plan quality in patients with prostate cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691646/
https://www.ncbi.nlm.nih.gov/pubmed/37559561
http://dx.doi.org/10.1002/acm2.14122
work_keys_str_mv AT tanakashohei evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT kadoyanoriyuki evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT ishizawamiyu evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT katsutayoshiyuki evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT araikazuhiro evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT takahashiharuna evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT xiaoyushan evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT takahashinoriyoshi evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT satokiyokazu evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT takedaken evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer
AT jingukeiichi evaluationofunity15tmrlinacplanqualityinpatientswithprostatecancer